Tags

Type your tag names separated by a space and hit enter

[Osteodensitometry in children and adolescents with inflammatory bowel disease].
Rofo. 2007 Jan; 179(1):58-64.ROFO

Abstract

PURPOSE

To evaluate the quantity and severity of bone disorders in children and adolescents with inflammatory bowel diseases (IBD) and to examine the correlation to whole body growth.

MATERIALS AND METHODS

In this study 89 bone mineral density measurements were performed and retrospectively analyzed.

RESULTS

Under consideration of growth retardation, over 65.2 % of the patients with Cohn's disease showed a reduced bone mineral density. Osteopenia/Osteoporosis is seldom seen in patients with ulcerative colitis, i. e., only 34.8 % showed a reduction in bone mineral density. Growth retardation and reduced bone mineral density are correlated. Patients with Cohn's disease and a body length below the 25th height percentile showed a reduced bone mineral density in 78.1 % of the cases. Patients with a body length below the 10th height percentile had a reduced bone mineral density in 83.3 % of the cases.

CONCLUSION

These results demonstrate the value of osteodensitometric measurements in patients with chronic diseases, especially in children and adolescents with inflammatory bowel disease.

Authors+Show Affiliations

Klinik und Poliklinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Leipzig. gerald.kluge@medizin.uni-leipzig.deNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Evaluation Study
Journal Article

Language

ger

PubMed ID

17203445

Citation

Kluge, G, et al. "[Osteodensitometry in Children and Adolescents With Inflammatory Bowel Disease]." RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, vol. 179, no. 1, 2007, pp. 58-64.
Kluge G, Borte M, Richter T, et al. [Osteodensitometry in children and adolescents with inflammatory bowel disease]. Rofo. 2007;179(1):58-64.
Kluge, G., Borte, M., Richter, T., Kahn, T., & Borte, G. (2007). [Osteodensitometry in children and adolescents with inflammatory bowel disease]. RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 179(1), 58-64.
Kluge G, et al. [Osteodensitometry in Children and Adolescents With Inflammatory Bowel Disease]. Rofo. 2007;179(1):58-64. PubMed PMID: 17203445.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Osteodensitometry in children and adolescents with inflammatory bowel disease]. AU - Kluge,G, AU - Borte,M, AU - Richter,T, AU - Kahn,T, AU - Borte,G, PY - 2007/1/5/pubmed PY - 2007/2/3/medline PY - 2007/1/5/entrez SP - 58 EP - 64 JF - RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin JO - Rofo VL - 179 IS - 1 N2 - PURPOSE: To evaluate the quantity and severity of bone disorders in children and adolescents with inflammatory bowel diseases (IBD) and to examine the correlation to whole body growth. MATERIALS AND METHODS: In this study 89 bone mineral density measurements were performed and retrospectively analyzed. RESULTS: Under consideration of growth retardation, over 65.2 % of the patients with Cohn's disease showed a reduced bone mineral density. Osteopenia/Osteoporosis is seldom seen in patients with ulcerative colitis, i. e., only 34.8 % showed a reduction in bone mineral density. Growth retardation and reduced bone mineral density are correlated. Patients with Cohn's disease and a body length below the 25th height percentile showed a reduced bone mineral density in 78.1 % of the cases. Patients with a body length below the 10th height percentile had a reduced bone mineral density in 83.3 % of the cases. CONCLUSION: These results demonstrate the value of osteodensitometric measurements in patients with chronic diseases, especially in children and adolescents with inflammatory bowel disease. SN - 1438-9029 UR - https://www.unboundmedicine.com/medline/citation/17203445/[Osteodensitometry_in_children_and_adolescents_with_inflammatory_bowel_disease]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2006-927302 DB - PRIME DP - Unbound Medicine ER -